Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

23/38 Nebulised therapy in patients with Chronic Obstructive Pulmonary Disease and disabling breathlessness

Opens

23 March 2023

Closes

13:00 on 26 July 2023

Contact

  • For help with your application contact htafunding@nihr.ac.uk
  • For more information about the funding Programme, visit the HTA Page
  • Got a research idea and not sure how to turn it into a funding application? The Research Design Service (RDS) supports health and social care researchers across England on all aspects of developing and writing a funding application. Find out how the RDS can help with your application.

Supporting Information

Please note that the Word version of the Stage 1 application form is to be used as a guide and to assist with completion of the online application form only, for example to see how many characters are accepted in each section and how the printed complete form is laid out. Please do not try to use this as an application form, you must apply using the online form available through the links available when calls are open. You should also refer to the application form guidance notes.

Studies within a trial or a review

  • This funding opportunity is eligible for researchers to embed a study within a trial or a review. These studies should evaluate alternative ways of undertaking a trial or a review process.

The Health Technology Assessment (HTA) Programme is accepting Stage 1 applications to their commissioned workstream for this primary research topic.

In order to apply you will need to carefully review the:

Applications received by the advertised closing date will be considered at a first-stage funding committee meeting, and successful applicants will then be invited to submit a Stage 2 application. Applicants will have 8 weeks to complete and submit their Stage 2 application form, which will then be considered at the following HTA funding committee meeting. For more information, please read the commissioning brief.

All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the Research Governance Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.

Studies within a trial or review

This funding opportunity is eligible for a SWAT/SWAR (study within a trial or study within a review), which can help significantly improve methodology of future research as well as the host study. Find out about the benefits of SWATs/SWARs and how to include one in your application

Australian National Health and Medical Research Council collaborations

The Australian National Health and Medical Research Council (NHMRC) is considering its next round of joint funding with the NIHR, and may include this funding opportunity. If so, the NHMRC will invest a total of up to $3 million AUD to cover the Australian component of all research projects selected for funding, under all the calls it is supporting. All applicants who wish to take advantage of this scheme should read the additional guidance for completing collaborative applications.

NHMRC will provide funding for the Australian-based Chief Investigator, in accordance with the standard NHMRC funding agreement and the NHMRC-NIHR Collaborative Research Grant Scheme guidelines. Please refer to the NHMRC website for more information. UK-only applications are also welcome.